Newron Pharmaceuticals S.p.A.

About Newron Pharmaceuticals S.p.A.

Newron Pharmaceuticals is a biopharmaceutical company focused on developing novel therapies for patients with diseases of the central and peripheral nervous system. Founded in 1999 and headquartered in Bresso, near Milan, Italy, with a subsidiary in Morristown, NJ, USA, Newron aims to address unmet needs in indications such as Parkinson's disease and schizophrenia through innovative treatments. Their team of around 30 scientists, researchers, and clinicians works on drug candidates from discovery to commercialization, supported by strong clinical research and partnerships.

Products & Services

Clinical Pipeline:A balanced and robust pipeline of drug candidates at different clinical stages for treating central and peripheral nervous system disorders.

Evenamide:A novel treatment under development as an adjunctive therapy for schizophrenia, with ongoing Phase III clinical trials and related intellectual property expansions.

Specialties

Central Nervous System (CNS) Drug Development Peripheral Nervous System Therapies Parkinson's Disease Treatment Schizophrenia Treatment

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Equity Financing T: - FT: Equity Financing	A: 41800000 MR: - FA: up to EUR 38 million FAN: 41800000	D: 2026-02-16 FD: 2026-02-16	1 investors

Equity Financing Latest

2026-02-16

$41.8M

1 investor (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

S

Stefan Weber

Executive director, CEO

R

Ravi Anand

CMO

R

Roberto Galli

CFO

D

Dennis Dionne

VP Commercial Affairs

F

Filippo Moriggia

VP Operations

L

Laura Faravelli

VP Business Development

View 8 more team members with Pro

Unlock Full Team Directory

Recent News